{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:27:57Z","timestamp":1782941277847,"version":"3.54.5"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>Pleural mesothelioma (PM) is an aggressive disease linked to asbestos exposure, presenting significant treatment challenges. The recommended approach is multimodal treatment, even if the concept of resectable PM and the superiority of one surgical technique over the other [(extended) pleurectomy decortication [(E)PD] vs extra-pleural pneumonectomy (EPP)] are matter of debates. The aim of this study is to compare the 2 techniques in terms of short- and long-term outcomes at a high-volume centre.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Clinical data from PM patients who underwent radical surgery [(E)PD and EPP] between 1994 and 2022 were collected. A propensity score weighting approach was used for non-random intervention allocation. Survival distribution was estimated using Kaplan\u2013Meier method and the association with outcomes was evaluated using a weighted Cox proportional hazard models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Among 254 patients, 125 (49%) underwent EPP and 129 (51%) (E)PD. The 90-day mortality was higher in the EPP group (7.2% vs 0%; P\u2009=\u20090.01). No difference in 1-, 3- and 5-year survival was found: 65.8%, 26%, 17% for EPP and 75.5%, 39.7% and 21.3% for (E)PD; P\u2009=\u20090.39. The multivariable-weighted Cox model identified no increased risk of death [hazard ratio (HR) 1.25; P\u2009=\u20090.49] or recurrence (HR 1.05; P\u2009=\u20090.858) in the EPP group. Pre-operative total lung capacity was significantly associated with a reduced risk of death (HR 0.96; P\u2009=\u20090.023) and recurrence (HR 0.97; P\u2009=\u20090.019) at follow-up, while pre-operative disease burden to a higher risk of recurrence (HR 1.01; P\u2009=\u20090.02).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Our experience showed acceptable short- and long-term outcomes in both procedures, making EPP still an option only for carefully selected patients at high-volume centre. Surgery, although recently debated, should be performed exclusively in expert centres to minimize post-operative risks. The identification of new prognostic factors is crucial for better selecting patients who may benefit from surgery within the context of multimodal treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejcts\/ezae431","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T16:59:22Z","timestamp":1732813162000},"source":"Crossref","is-referenced-by-count":2,"title":["Surgery for pleural mesothelioma in multimodality setting: comparison between surgical techniques in a high-volume centre"],"prefix":"10.1093","volume":"66","author":[{"given":"Eleonora","family":"Faccioli","sequence":"first","affiliation":[{"name":"Thoracic Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dell\u2019Amore","sequence":"additional","affiliation":[{"name":"Thoracic Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Lorenzoni","sequence":"additional","affiliation":[{"name":"Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Schiavon","sequence":"additional","affiliation":[{"name":"Thoracic Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Canu","sequence":"additional","affiliation":[{"name":"Thoracic Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pasello","sequence":"additional","affiliation":[{"name":"Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS , Padova,","place":["Italy"]},{"name":"Department of Surgery, Oncology and Gastroenterology, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Zambello","sequence":"additional","affiliation":[{"name":"Thoracic Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Sepulcri","sequence":"additional","affiliation":[{"name":"Radiation Therapy Unit, Istituto Oncologico Veneto IOV-IRCCS , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Sambataro","sequence":"additional","affiliation":[{"name":"Thoracic Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Labella","sequence":"additional","affiliation":[{"name":"Unit of Advanced Clinical and Translational Imaging, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Giraudo","sequence":"additional","affiliation":[{"name":"Unit of Advanced Clinical and Translational Imaging, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Gregori","sequence":"additional","affiliation":[{"name":"Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Calabrese","sequence":"additional","affiliation":[{"name":"Pathology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Rea","sequence":"additional","affiliation":[{"name":"Thoracic Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"2024121419363777500_ezae431-B1","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S1470-2045(20)30462-9","article-title":"Durvalumab with first-line chemotherapy in previously untreated malignant pleurale mesothelioma (DREAM). A multicentre, single-arm, phase 2 trial with safety run-in","volume":"21","author":"Nowak","year":"2020","journal-title":"Lancet Oncol"},{"key":"2024121419363777500_ezae431-B2","doi-asserted-by":"crossref","first-page":"836751","DOI":"10.3389\/fonc.2022.836751","article-title":"Complete pathological response after neoadjuvant chemo-immunotherapy in Malignant pleural mesothelioma","volume":"12","author":"Tostes","year":"2022","journal-title":"Front Oncol"},{"key":"2024121419363777500_ezae431-B3","doi-asserted-by":"crossref","first-page":"1378530","DOI":"10.3389\/fonc.2024.1378530","article-title":"Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy","volume":"14","author":"Faccioli","year":"2024","journal-title":"Front Oncol"},{"key":"2024121419363777500_ezae431-B4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.annonc.2021.11.005","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"33","author":"Popat","year":"2022","journal-title":"Ann Oncol"},{"key":"2024121419363777500_ezae431-B5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jtcvs.2013.01.039","article-title":"The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston MA","volume":"145","author":"Rusch","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024121419363777500_ezae431-B6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guidelines","volume":"36","author":"Kindler","year":"2018","journal-title":"J Clin Oncol"},{"key":"2024121419363777500_ezae431-B7","author":"National Comprehensive Cancer Network"},{"key":"2024121419363777500_ezae431-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ejcts\/ezaa158","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"58","author":"Opitz","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024121419363777500_ezae431-B9","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jtho.2018.08.2036","article-title":"Current and future management of malignant pleural mesothelioma: a consensus report of the International Association for the Study of Lung Cancer and Mesothelioma applied research foundation","volume":"13","author":"Tsao","year":"2018","journal-title":"J Thorac Oncol"},{"key":"2024121419363777500_ezae431-B10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomized feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"2024121419363777500_ezae431-B11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(11)70307-2","article-title":"The MARS feasibility trial: conclusions not supported by data","volume":"12","author":"Weder","year":"2011","journal-title":"Lancet Oncol"},{"key":"2024121419363777500_ezae431-B12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.athoracsur.2014.09.056","article-title":"Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma","volume":"99","author":"Taioli","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"2024121419363777500_ezae431-B13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.athoracsur.2021.04.078","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication for malignant pleural mesothelioma","volume":"113","author":"Zhou","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"2024121419363777500_ezae431-B14","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.3390\/jcm11195544","article-title":"Systematic review and meta-analysis of pleurectomy\/decortication versus extra-pleural pneumonectomy in the treatment of malignant pleural mesothelioma","volume":"11","author":"Danuzzo","year":"2022","journal-title":"J Clin Med"},{"key":"2024121419363777500_ezae431-B15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-2600(24)00119-X","article-title":"Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial","volume":"12","author":"Lim","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2024121419363777500_ezae431-B16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S2213-2600(24)00146-2","article-title":"MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma","volume":"12","author":"Grosso","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2024121419363777500_ezae431-B17","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.3390\/jcm10194407","article-title":"Spirometry and computed tomography can predict unresectability in malignant pleural mesothelioma","volume":"10","author":"Bellini","year":"2021","journal-title":"J Clin Med"},{"key":"2024121419363777500_ezae431-B18","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.3390\/cancers14153699","article-title":"Sarcopenia as a predictor of short- and long-term outcomes in patients surgically treated for malignant pleural mesothelioma","volume":"14","author":"Faccioli","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2024121419363777500_ezae431-B19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jtho.2018.04.034","article-title":"Revised modified response evaluation criteria in solid tumors for assessment of response in malignant pleural mesothelioma (version 1.1)","volume":"13","author":"Armato","year":"2018","journal-title":"J Thorac Oncol"},{"key":"2024121419363777500_ezae431-B20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.6004\/jnccn.2024.0014","article-title":"NCCN guidelines insights: mesothelioma: pleural, version 1.2024","volume":"22","author":"Stevenson","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"2024121419363777500_ezae431-B21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins and extrapleural nodal status and cell type determine post-operative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024121419363777500_ezae431-B22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1510\/icvts.2010.251488","article-title":"A survey of opinions and beliefs concerning surgery for malig- nant pleural mesothelioma amongst 802 members of the European Association for Cardio Thoracic Surgery (EACTS), the European Society of Thoracic Surgeons (ESTS) and the society of Thoracic Surgeons (STS)","volume":"12","author":"Treasure","year":"2011","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2024121419363777500_ezae431-B23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jtcvs.2015.10.054","article-title":"The mesothelioma surgery shift","volume":"151","author":"Flores","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024121419363777500_ezae431-B24","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s13304-022-01369-4","article-title":"Meta-analysis of survival after extrapleural pneumonectomy (EPP) versus pleurectomy decortication (P\/D) for malignant pleural mesothelioma in the context of macroscopic complete resection (MCR)","volume":"74","author":"Magouliotis","year":"2022","journal-title":"Updates Surg"},{"key":"2024121419363777500_ezae431-B25","doi-asserted-by":"crossref","first-page":"2302114","DOI":"10.1183\/13993003.02114-2023","article-title":"A randomized phase II study of extended pleurectomy\/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205","volume":"63","author":"Raskin","year":"2024","journal-title":"Eur Respir J"},{"key":"2024121419363777500_ezae431-B26","first-page":"977","article-title":"Extended pleurectomy\/decortication and hypertermic intraoperative intrapleural cisplatin perfusion for malignant pleural mesothelioma","volume":"16","author":"Okubo","year":"2023","journal-title":"JCTVS Open"},{"key":"2024121419363777500_ezae431-B27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/thoraxjnl-2021-218214","article-title":"Cytoreductive surgery with hypertermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systematic review","volume":"78","author":"Dawson","year":"2023","journal-title":"Thorax"},{"key":"2024121419363777500_ezae431-B28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/JTO.0b013e31824ab6c5","article-title":"Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma","volume":"7","author":"Lang-Lazdunski","year":"2012","journal-title":"J Thorac Oncol"},{"key":"2024121419363777500_ezae431-B29","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejcts.2009.07.032","article-title":"Three decades of experience in the surgical multi-modality management of pleural mesothelioma","volume":"37","author":"Luckraz","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024121419363777500_ezae431-B30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.lungcan.2011.12.009","article-title":"Extrapleural pneumonectomy for early-stage malignant pleural mesothelioma: a harmful procedure","volume":"77","author":"Rena","year":"2012","journal-title":"Lung Cancer"},{"key":"2024121419363777500_ezae431-B31","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/ejcts\/ezv403","article-title":"The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy\/decortication","volume":"49","author":"Sharkey","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024121419363777500_ezae431-B32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JTO.0000000000000064","article-title":"Does surgery improve survival of patients with malignant mesothelioma? A multicenter retrospective analysis of 1365 consecutive patients","volume":"9","author":"Bovolato","year":"2014","journal-title":"J Thorac Oncol"},{"key":"2024121419363777500_ezae431-B33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S1010-7940(03)00376-2","article-title":"Treatment of mesothelioma in Bloemfontein, South Africa","volume":"24","author":"de Vries","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024121419363777500_ezae431-B34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024121419363777500_ezae431-B35","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2017.73.8401","article-title":"Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: propensity score matching analysis","volume":"35","author":"Nelson","year":"2017","journal-title":"J Clin Oncol"},{"key":"2024121419363777500_ezae431-B36","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/icvts\/ivw422","article-title":"Propensity matched comparison of extrapleural pneumonectomy and pleurectomy decortication for pleural mesothelioma patients","volume":"24","author":"Kostron","year":"2017","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2024121419363777500_ezae431-B37","doi-asserted-by":"crossref","first-page":"emac 153","DOI":"10.1093\/ejcts\/ezac153","article-title":"Multimodality treatment of malignant pleural mesothelioma: evolving patient selection criteria using scores","volume":"62","author":"Bolukbas","year":"2022","journal-title":"Eur J Cardiothor Surgery"},{"key":"2024121419363777500_ezae431-B38","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jtho.2024.03.007","article-title":"The International Association for the Study of Lung Cancer Mesothelioma Staging Project: proposals for revisions of the \u201cT\u201d descriptors in the forthcoming ninth edition of the TNM classification for pleural mesothelioma","volume":"19","author":"Gill","year":"2024","journal-title":"J Thorac Oncol"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezae431\/60897182\/ezae431.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/66\/6\/ezae431\/61167015\/ezae431.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/66\/6\/ezae431\/61167015\/ezae431.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T19:36:50Z","timestamp":1734205010000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezae431\/7912433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezae431","relation":{},"ISSN":["1873-734X"],"issn-type":[{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,11,28]]},"article-number":"ezae431"}}